Literature DB >> 29511457

Downregulation of FoxM1 inhibits cell growth and migration and invasion in bladder cancer cells.

Xinping Yang1, Yuanyuan Shi2, Jingzhe Yan3, Haitao Fan4.   

Abstract

The FoxM1 (Forkhead Box M1) transcription factor plays a key role in regulation of cell growth, cell cycle, and transformation. Higher expression of FoxM1 has been observed in various types of human cancers including bladder cancer. However, the exact function of FoxM1 in bladder cancer has not been elucidated. To investigate the cellular and molecular function of FoxM1 in bladder cancer, we measured the consequences of downregulation and upregulation of FoxM1 in bladder cancer cells using MTT assay, wound healing assay, and invasion assay. We found that downregulation of FoxM1 inhibited cell growth, but induced apoptosis in bladder cancer cells. Moreover, we found that inhibition of FoxM1 retarded cell migration and invasion. In line with this, upregulation of FoxM1 led to cell growth promotion and inhibited cell apoptosis in bladder cancer cells. Consistently, upregulation of FoxM1 led to increased cell migration and invasion. Our Western blotting results identified that downregulation of FoxM1 increased p27 level and inhibited VEGF, while overexpression of FoxM1 reduced p27 level and increased VEGF. Our findings suggest that FoxM1 could be a useful target for the treatment of bladder cancer.

Entities:  

Keywords:  FoxM1; apoptosis; bladder cancer; cell growth; invasion

Year:  2018        PMID: 29511457      PMCID: PMC5835828     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  36 in total

Review 1.  FOXM1, a typical proliferation-associated transcription factor.

Authors:  Inken Wierstra; Jürgen Alves
Journal:  Biol Chem       Date:  2007-12       Impact factor: 3.915

Review 2.  FOXM1 in Cancer: Interactions and Vulnerabilities.

Authors:  Andrei L Gartel
Journal:  Cancer Res       Date:  2017-06-05       Impact factor: 12.701

Review 3.  The transcription factor FOXM1 (Forkhead box M1): proliferation-specific expression, transcription factor function, target genes, mouse models, and normal biological roles.

Authors:  Inken Wierstra
Journal:  Adv Cancer Res       Date:  2013       Impact factor: 6.242

Review 4.  Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends.

Authors:  Sebastien Antoni; Jacques Ferlay; Isabelle Soerjomataram; Ariana Znaor; Ahmedin Jemal; Freddie Bray
Journal:  Eur Urol       Date:  2016-06-28       Impact factor: 20.096

Review 5.  Prognostic value of FOXM1 in solid tumors: a systematic review and meta-analysis.

Authors:  Lijun Li; Dang Wu; Qun Yu; Lingdi Li; Pin Wu
Journal:  Oncotarget       Date:  2017-05-09

6.  FOXM1 predicts overall and disease specific survival in muscle-invasive urothelial carcinoma and presents a differential expression between bladder cancer subtypes.

Authors:  Sebastien Rinaldetti; Ralph Markus Wirtz; Thomas Stefan Worst; Markus Eckstein; Cleo Aaron Weiss; Johannes Breyer; Wolfgang Otto; Christian Bolenz; Arndt Hartmann; Philipp Erben
Journal:  Oncotarget       Date:  2017-07-18

Review 7.  Narrow band imaging-assisted transurethral resection reduces the recurrence risk of non-muscle invasive bladder cancer: A systematic review and meta-analysis.

Authors:  Weiting Kang; Zilian Cui; Qianqian Chen; Dong Zhang; Haiyang Zhang; Xunbo Jin
Journal:  Oncotarget       Date:  2017-04-04

Review 8.  Mechanisms and regulation of endothelial VEGF receptor signalling.

Authors:  Michael Simons; Emma Gordon; Lena Claesson-Welsh
Journal:  Nat Rev Mol Cell Biol       Date:  2016-07-27       Impact factor: 94.444

Review 9.  The roles of FOXM1 in pancreatic stem cells and carcinogenesis.

Authors:  Ming Quan; Peipei Wang; Jiujie Cui; Yong Gao; Keping Xie
Journal:  Mol Cancer       Date:  2013-12-10       Impact factor: 27.401

10.  A greater number of dissected lymph nodes is associated with more favorable outcomes in bladder cancer treated by radical cystectomy: a meta-analysis.

Authors:  Fei Li; Xuwei Hong; Lina Hou; Fengsheng Lin; Pengliang Chen; Shiyu Pang; Yuejun Du; He Huang; Wanlong Tan
Journal:  Oncotarget       Date:  2016-09-20
View more
  9 in total

1.  FOXM1 plays a role in autophagy by transcriptionally regulating Beclin-1 and LC3 genes in human triple-negative breast cancer cells.

Authors:  Zuhal Hamurcu; Nesrin Delibaşı; Ufuk Nalbantoglu; Elif Funda Sener; Nursultan Nurdinov; Bayram Tascı; Serpil Taheri; Yusuf Özkul; Hamiyet Donmez-Altuntas; Halit Canatan; Bulent Ozpolat
Journal:  J Mol Med (Berl)       Date:  2019-02-07       Impact factor: 4.599

2.  Glycogen synthase kinase-3β inhibits tubular regeneration in acute kidney injury by a FoxM1-dependent mechanism.

Authors:  Sonali Sinha; Nidhi Dwivedi; James Woodgett; Shixin Tao; Christianna Howard; Timothy A Fields; Abeda Jamadar; Reena Rao
Journal:  FASEB J       Date:  2020-08-19       Impact factor: 5.191

3.  Diosgenin Exerts Antitumor Activity via Downregulation of Skp2 in Breast Cancer Cells.

Authors:  Yanling Liu; Zijun Zhou; Jingzhe Yan; Xuefeng Wu; Guiying Xu
Journal:  Biomed Res Int       Date:  2020-06-16       Impact factor: 3.411

4.  Role of FOXM1 in vascular smooth muscle cell survival and neointima formation following vascular injury.

Authors:  Sarah Franco; Amelia Stranz; Fiona Ljumani; Go Urabe; Mirnal Chaudhary; Danielle Stewart; Vijaya Satish Pilli; Matthew Kelly; Dai Yamanouchi; K Craig Kent; Bo Liu
Journal:  Heliyon       Date:  2020-06-16

5.  Thyrotroph embryonic factor is downregulated in bladder cancer and suppresses proliferation and tumorigenesis via the AKT/FOXOs signalling pathway.

Authors:  Jianan Yang; Bin Wang; Han Chen; Xuhong Chen; Jing Li; Yanfei Chen; Daozhang Yuan; Shunsheng Zheng
Journal:  Cell Prolif       Date:  2018-12-04       Impact factor: 6.831

6.  Antitumor Effects of Paeoniflorin on Hippo Signaling Pathway in Gastric Cancer Cells.

Authors:  Kai Niu; Yanling Liu; Zijun Zhou; Xuefeng Wu; Huaiwu Wang; Jingzhe Yan
Journal:  J Oncol       Date:  2021-01-19       Impact factor: 4.375

7.  Aberrantly high activation of a FoxM1-STMN1 axis contributes to progression and tumorigenesis in FoxM1-driven cancers.

Authors:  Jun Liu; Jipeng Li; Ke Wang; Haiming Liu; Jianyong Sun; Xinhui Zhao; Yanping Yu; Yihuan Qiao; Ye Wu; Xiaofang Zhang; Rui Zhang; Angang Yang
Journal:  Signal Transduct Target Ther       Date:  2021-02-01

Review 8.  A narrative review of research progress on FoxM1 in breast cancer carcinogenesis and therapeutics.

Authors:  Yan-Ling Zhang; Yan Ma; You-Qin Zeng; Yan Liu; En-Ping He; Yi-Tong Liu; Feng-Ling Qiao; Rong Yu; Ying-Shuang Wang; Xin-Yu Wu; Ping Leng
Journal:  Ann Transl Med       Date:  2021-11

9.  Identification of a 13‑mRNA signature for predicting disease progression and prognosis in patients with bladder cancer.

Authors:  Hubin Yin; Chen Zhang; Xin Gou; Weiyang He; Daoju Gan
Journal:  Oncol Rep       Date:  2019-12-12       Impact factor: 3.906

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.